Macitentan treatment retards the progression of established pulmonary arterial hypertension in an animal model.

Background Macitentan is a new endothelin receptor antagonist that is used to treat pulmonary arterial hypertension in humans. Treatment of established pulmonary hypertension with macitentan was studied using the monocrotaline model of pulmonary hypertension.